 | Biomarkers in Alzheimer's Disease Biomarkers in Alzheimer's Disease provides a comprehensive overview of all modalities of Alzheimer's disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer's disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's disease, and for differential diagnosis of Alzheimer's disease with other non-Alzheimer's dementia. Tapan Kumar Khan, PhD Blanchette Rockefeller Neurosciences Institute, Morgantown, WV, United States Dr Tapan Khan is an Associate Professor at the Blanchette Rockefeller Neurosciences Institute in Morgantown, West Virginia. He is the lead investigator for the development of noninvasive diagnostics for Alzheimer's disease at the Institute. He is also an associate editor of the Journal of Alzheimer's Disease. |
